Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells.
Irandoust M, Alvarez Zarate J, Hubeek I, van Beek EM, Schornagel K, Broekhuizen AJ, Akyuz M, van de Loosdrecht AA, Delwel R, Valk PJ, Sonneveld E, Kearns P, Creutzig U, Reinhardt D, de Bont ES, Coenen EA, van den Heuvel-Eibrink MM, Zwaan CM, Kaspers GJ, Cloos J, van den Berg TK. Irandoust M, et al. PLoS One. 2013;8(1):e52143. doi: 10.1371/journal.pone.0052143. Epub 2013 Jan 8. PLoS One. 2013. PMID: 23320069 Free PMC article.
Novel role of WD40 and SOCS box protein-2 in steady-state distribution of granulocyte colony-stimulating factor receptor and G-CSF-controlled proliferation and differentiation signaling.
Erkeland SJ, Aarts LH, Irandoust M, Roovers O, Klomp A, Valkhof M, Gits J, Eyckerman S, Tavernier J, Touw IP. Erkeland SJ, et al. Among authors: irandoust m. Oncogene. 2007 Mar 29;26(14):1985-94. doi: 10.1038/sj.onc.1210004. Epub 2006 Sep 25. Oncogene. 2007. PMID: 17001306
Corrigendum to "Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy" [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240].
Masjedi A, Ahmadi A, Ghanee S, Malakotikhah F, Afjadi MN, Irandoust M, Kiani FK, Asl SH, Atyabi F, Hassannia H, Hojjat-Farsangi M, Namdar A, Ghalamfarsa G, Jadidi-Niaragh F. Masjedi A, et al. Among authors: irandoust m. Nanomedicine. 2023 Jul;51:102690. doi: 10.1016/j.nano.2023.102690. Epub 2023 May 9. Nanomedicine. 2023. PMID: 37167816 No abstract available.
Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy.
Masjedi A, Ahmadi A, Ghani S, Malakotikhah F, Nabi Afjadi M, Irandoust M, Karoon Kiani F, Heydarzadeh Asl S, Atyabi F, Hassannia H, Hojjat-Farsangi M, Namdar A, Ghalamfarsa G, Jadidi-Niaragh F. Masjedi A, et al. Among authors: irandoust m. Nanomedicine. 2020 Oct;29:102240. doi: 10.1016/j.nano.2020.102240. Epub 2020 Jun 15. Nanomedicine. 2020. PMID: 32553948
Concomitant blockade of A2AR and CTLA-4 by siRNA-loaded polyethylene glycol-chitosan-alginate nanoparticles synergistically enhances antitumor T-cell responses.
Ghasemi-Chaleshtari M, Kiaie SH, Irandoust M, Karami H, Nabi Afjadi M, Ghani S, Aghaei Vanda N, Ghaderi Sede MJ, Ahmadi A, Masjedi A, Hassannia H, Atyabi F, Hojjat-Farsangi M, Namdar A, Ghalamfarsa G, Jadidi-Niaragh F. Ghasemi-Chaleshtari M, et al. Among authors: irandoust m. J Cell Physiol. 2020 Dec;235(12):10068-10080. doi: 10.1002/jcp.29822. Epub 2020 Jun 2. J Cell Physiol. 2020. PMID: 32488862
Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer.
Salimifard S, Masjedi A, Hojjat-Farsangi M, Ghalamfarsa G, Irandoust M, Azizi G, Mohammadi H, Keramati MR, Jadidi-Niaragh F. Salimifard S, et al. Among authors: irandoust m. Pathol Res Pract. 2020 May;216(5):152915. doi: 10.1016/j.prp.2020.152915. Epub 2020 Mar 2. Pathol Res Pract. 2020. PMID: 32146002 Review.
21 results